amikacin has been researched along with Obesity in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, LA; Bell, RM; Blouin, RA; Griffen, WO; Record, KE | 1 |
| Abou-Samra, M; Brichard, SM; Davis-López de Carrizosa, MA; Dubuisson, N; Gillard, J; Leclercq, IA; Nachit, M; Noel, L; Selvais, CM; Versele, R | 1 |
| Chabry, J; Gautier, N; Nicolas, S; Pisani, DF; Rochet, N | 1 |
| Iwabu, M; Kadowaki, T; Kadowaki, Y; Kobori, T; Miyata, K; Odawara, S; Ohuchi, N; Okada-Iwabu, M; Tanabe, H; Yamauchi, T; Yokoyama, S | 1 |
| Akimoto, M; Koshikawa, N; Nagase, H; Takenaga, K | 1 |
| Kim, Y; Park, CW | 1 |
| Hamagami, K; Honma, T; Iwabu, M; Kadowaki, T; Kimura-Someya, T; Matsuda, K; Nagano, T; Ogata, H; Okada-Iwabu, M; Shirouzu, M; Tanabe, H; Tanaka, A; Tokuyama, K; Ueki, K; Yamaguchi, M; Yamauchi, T; Yokoyama, S | 1 |
| Holland, WL; Scherer, PE | 1 |
1 review(s) available for amikacin and Obesity
| Article | Year |
|---|---|
Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease.
Topics: Adiponectin; Animals; Diabetes Mellitus, Type 2; Humans; Kidney; Lipid Metabolism; Obesity; Oxidative Stress; Piperidines; Receptors, Adiponectin | 2019 |
7 other study(ies) available for amikacin and Obesity
| Article | Year |
|---|---|
Amikacin pharmacokinetics in morbidly obese patients.
Topics: Adult; Amikacin; Body Weight; Female; Humans; Kanamycin; Kinetics; Male; Middle Aged; Models, Biological; Obesity | 1980 |
AdipoRon enhances healthspan in middle-aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers.
Topics: Animals; Insulin Resistance; Lipids; Mice; Mice, Obese; Muscle, Skeletal; Non-alcoholic Fatty Liver Disease; Obesity; X-Ray Microtomography | 2023 |
The adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice.
Topics: Abdominal Fat; Animals; Bone Development; Carbohydrate Metabolism; Disease Models, Animal; Disease Progression; Glucocorticoids; Glucose; Growth Disorders; Male; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Receptors, Adiponectin | 2020 |
AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice.
Topics: Animals; Drug Evaluation, Preclinical; Exercise Tolerance; Insulin Resistance; Male; Mice; Mice, Knockout; Obesity; Piperidines; Receptors, Adiponectin | 2021 |
Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice.
Topics: Animals; Cell Line, Tumor; Diet, High-Fat; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Male; Mice; Obesity; Pancreatic Neoplasms; Piperidines; Receptors, Adiponectin | 2021 |
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
Topics: Adenylate Kinase; Adiponectin; Adipose Tissue, White; Administration, Oral; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Evaluation, Preclinical; Dyslipidemias; Enzyme Activation; Glucose Intolerance; Inflammation; Insulin Resistance; Liver; Longevity; Mice; Mitochondria; Muscle Fibers, Skeletal; Muscles; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Piperidines; PPAR alpha; Receptors, Adiponectin; Signal Transduction; Small Molecule Libraries; Transcription Factors; Triglycerides | 2013 |
Cell Biology. Ronning after the adiponectin receptors.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Apoptosis; Ceramidases; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoglycemic Agents; Insulin Resistance; Mice; Molecular Mimicry; Molecular Targeted Therapy; Obesity; Piperidines; Receptors, Adiponectin | 2013 |